Assertio Holdings Inc (ASRT)
2.51
+0.09
(+3.72%)
USD |
NASDAQ |
Oct 04, 13:07
Assertio Holdings Price: 2.51 for Oct. 4, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 03, 2023 | 2.48 | 2.54 | 2.42 | 2.42 | 1.153M |
| Oct 02, 2023 | 2.56 | 2.57 | 2.428 | 2.45 | 2.148M |
| Sep 29, 2023 | 2.63 | 2.63 | 2.53 | 2.56 | 1.339M |
| Sep 28, 2023 | 2.63 | 2.70 | 2.62 | 2.64 | 1.070M |
| Sep 27, 2023 | 2.59 | 2.680 | 2.59 | 2.63 | 1.080M |
| Sep 26, 2023 | 2.58 | 2.69 | 2.57 | 2.58 | 1.213M |
| Sep 25, 2023 | 2.56 | 2.63 | 2.56 | 2.58 | 846095.0 |
| Sep 22, 2023 | 2.52 | 2.66 | 2.52 | 2.60 | 1.636M |
| Sep 21, 2023 | 2.58 | 2.58 | 2.50 | 2.52 | 1.914M |
| Sep 20, 2023 | 2.65 | 2.700 | 2.60 | 2.61 | 1.409M |
| Sep 19, 2023 | 2.63 | 2.70 | 2.595 | 2.65 | 1.388M |
| Sep 18, 2023 | 2.74 | 2.76 | 2.60 | 2.65 | 2.361M |
| Sep 15, 2023 | 2.77 | 2.80 | 2.680 | 2.755 | 2.164M |
| Sep 14, 2023 | 2.92 | 2.94 | 2.62 | 2.78 | 5.518M |
| Sep 13, 2023 | 2.96 | 3.05 | 2.92 | 2.94 | 1.451M |
| Sep 12, 2023 | 3.03 | 3.06 | 2.962 | 2.97 | 1.815M |
| Sep 11, 2023 | 3.18 | 3.19 | 2.935 | 3.05 | 2.693M |
| Sep 08, 2023 | 3.24 | 3.27 | 3.16 | 3.17 | 1.188M |
| Sep 07, 2023 | 3.19 | 3.275 | 3.15 | 3.24 | 1.223M |
| Sep 06, 2023 | 3.27 | 3.27 | 3.17 | 3.19 | 1.250M |
| Sep 05, 2023 | 3.30 | 3.34 | 3.23 | 3.27 | 1.422M |
| Sep 01, 2023 | 3.31 | 3.40 | 3.24 | 3.30 | 4.954M |
| Aug 31, 2023 | 3.27 | 3.311 | 3.20 | 3.28 | 1.485M |
| Aug 30, 2023 | 3.27 | 3.32 | 3.21 | 3.27 | 980940.0 |
| Aug 29, 2023 | 3.28 | 3.35 | 3.26 | 3.28 | 967176.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.86
Minimum
Oct 06 2021
23.68
Maximum
Oct 18 2018
5.566
Average
3.294
Median
Price Benchmarks
| MannKind Corp | 3.90 |
| Aravive Inc | 0.1175 |
| Aptevo Therapeutics Inc | 0.3153 |
| Xeris Biopharma Holdings Inc | 1.67 |
| Applied Therapeutics Inc | 2.175 |
Price Related Metrics
| PE Ratio | 1.696 |
| PS Ratio | 0.9180 |
| PEG Ratio | 0.0097 |
| Price to Book Value | 0.9191 |
| Price to Free Cash Flow | 1.989 |
| Earnings Yield | 58.96% |
| Market Cap | 233.70M |
| PEGY Ratio | 0.0097 |
| Operating PE Ratio | 2.602 |
| Normalized PE Ratio | 1.422 |